KD Logo

Taking a Closer Look At Organogenesis Holdings Inc (ORGO) Following Its Recent Trade

Organogenesis Holdings Inc’s recently made public that its President and CEO Gillheeney Gary S. unloaded Company’s shares for reported $0.14 million on Dec 09 ’24. In the deal valued at $3.52 per share,41,052 shares were sold. As a result of this transaction, Gillheeney Gary S. now holds 3,359,726 shares worth roughly $12.36 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Gillheeney Gary S. sold 18,416 shares, generating $67,218 in total proceeds. Upon selling the shares at $3.65, the President and CEO now owns 3,400,778 shares.

Before that, Gillheeney Gary S. bought 380,000 shares. Organogenesis Holdings Inc shares valued at $1,364,200 were divested by the Officer at a price of $3.59 per share.

Lake Street initiated its Organogenesis Holdings Inc [ORGO] rating to a Buy in a research note published on June 28, 2024; the price target was $5. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in early February with a ‘”an Overweight”‘ rating. Morgan Stanley began covering ORGO with “an Equal-weight” recommendation on June 15, 2023. BTIG Research revised its rating on May 24, 2023. It rated ORGO as “a Buy” which previously was an “a Neutral”.

Price Performance Review of ORGO

On Tuesday, Organogenesis Holdings Inc [NASDAQ:ORGO] saw its stock jump 5.14% to $3.68. Over the last five days, the stock has lost -7.30%. Organogenesis Holdings Inc shares have fallen nearly -10.02% since the year began. Nevertheless, the stocks have risen 10.51% over the past one year. While a 52-week high of $4.70 was reached on 01/08/24, a 52-week low of $2.16 was recorded on 04/25/24. SMA at 50 days reached $3.37, while 200 days put it at $2.92.

Levels Of Support And Resistance For ORGO Stock

The 24-hour chart illustrates a support level at 3.50, which if violated will result in even more drops to 3.33. On the upside, there is a resistance level at 3.80. A further resistance level may holdings at 3.93. The Relative Strength Index (RSI) on the 14-day chart is 50.84, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.23, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 69.74%. Stochastics %K at 16.29% indicates the stock is a buying.

How much short interest is there in Organogenesis Holdings Inc?

A steep rise in short interest was recorded in Organogenesis Holdings Inc stocks on 2024-11-29, dropping by -1.27 million shares to a total of 8.52 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 9.79 million shares. There was a decline of -14.92%, which implies that there is a negative sentiment for the stock.

Most Popular